神经母细胞瘤患者多发性转移:123I-MIBG SPECT/CT完全阴性而68Ga-DOTATATE PET/CT强阳性
一名有神经母细胞瘤病史的6岁男孩在化疗后出现骨髓微小残留病(MRD)阳性,123I-MIBG SPECT/CT未见任何摄取病灶,因MRD阳性且临床高度怀疑复发,随后行68Ga-DOTATATE PET/CT,发现多发性68Ga-DOTATATE高摄取转移灶,组织病理学检查证实为神经母细胞瘤转移,本病例强调在123I-MIBG阴性的患者中,尤其存在潜在复发指征时,68Ga-DOTATATE PET/CT具有补充诊断价值。
要点
- 6岁神经母细胞瘤男孩化疗后骨髓MRD阳性,123I-MIBG SPECT/CT完全阴性。
- 因MRD阳性且临床高度怀疑复发,行68Ga-DOTATATE PET/CT发现多发性高摄取转移灶。
- 组织病理学证实神经母细胞瘤转移,提示68Ga-DOTATATE PET/CT在MIBG阴性时具补充诊断价值。
核心结论
- 本病例强调在123I-MIBG阴性的患者中,尤其存在潜在复发指征时,68Ga-DOTATATE PET/CT具有补充诊断价值。
研究设计与样本
- 病例报告:一名有神经母细胞瘤病史的6岁男孩,化疗后出现骨髓微小残留病(MRD)阳性。
主要发现
- 123I-MIBG SPECT/CT未显示任何高摄取病灶。
- 因MRD阳性且临床高度怀疑疾病复发,随后行68Ga-DOTATATE PET/CT,发现多发性68Ga-DOTATATE高摄取转移灶。
- 组织病理学检查证实神经母细胞瘤转移的诊断。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A 6-year-old boy with a history of neuroblastoma following chemotherapy presented with positive bone marrow minimal residual disease (MRD). 123 I-MIBG SPECT/CT did not reveal any avid lesions, given the positive MRD and high clinical suspicion for disease recurrence, a subsequent 68 Ga-DOTATATE PET/CT was performed. This modality identified multiple metastatic lesions that were avid for 68 Ga-DOTATATE. Histopathological examination confirmed the diagnosis of neuroblastoma metastasis. This case underscores the complementary diagnostic value of 68 Ga-DOTATATE PET/CT in patients with negative 123I-MIBG findings, particularly when there are indications of potential relapse.
引用
- Zhang K, Li S, Zhou Z, et al. Completely Negative 123 I-MIBG SPECT/CT, but Strong Positive 68 Ga-DOTATATE PET/CT of Multiple Metastases in a Neuroblastoma Patient. Clin Nucl Med. 2025. PMID: 40494383. doi:10.1097/RLU.0000000000006011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。